Skip to main content
Screener/Healthcare/Biotechnology

NAMS — NewAmsterdam Pharma Company N.V.

NASDAQ
$31.23+0.41 (+1.31%)
Mid CapUnder $50HealthcareLow Beta
$17.63
$42.20
$30.31
$31.34
EPS (TTM)$-1.81
P/E Ratio-16.12
Dividend Yield—
Market Cap$3.49B
Volume695K
Prev Close$30.82
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$3.0M$0$-0.400.0%0.0%
Q4 '25$32K-$74.9M$-0.65-84.4%-234134.4%
Q3 '25$348K-$72.0M$-0.61100.0%-20691.1%
Q2 '25$19.1M-$17.4M$-0.15100.0%-90.7%
Q1 '25$3.0M-$39.5M$-0.34100.0%-1327.3%
Q4 '24$12.8M-$92.2M$-0.98100.0%-721.7%
Q3 '24$29.1M-$16.6M$-0.18100.0%-57.2%
Q2 '24$2.3M-$39.0M$-0.41100.0%-1711.6%
Get Your Daily Market Recap